Toxicity of first-line drugs for treatment of tuberculosis in children: Review

Tropical Medicine and International Health

Volumn 14, Issue 11, 2009, Pages 1329-1337

  Frydenberg, Alexis R ^a   Graham, Stephen M ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Co morbidity; First line drugs; HIV; Literature review; Malnutrition; Tuberculosis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE;

CHILD HEALTH; DRUG; DRUG PRESCRIBING; HEALTH CARE; HEALTH SURVEY; HUMAN IMMUNODEFICIENCY VIRUS; LITERATURE REVIEW; MALNUTRITION; MORBIDITY; SYMPTOM; TOXICITY; TUBERCULOSIS;

ACUTE KIDNEY FAILURE; ARTHRALGIA; ATAXIA; CHILD CARE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG ERUPTION; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; DRUG WITHDRAWAL; EOSINOPHILIA; EPIGASTRIC PAIN; EXTRAPULMONARY TUBERCULOSIS; EYE TOXICITY; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; GOUT; HEMOGLOBINURIA; HEMOLYTIC ANEMIA; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAUNDICE; KIDNEY INJURY; LIVER FAILURE; LIVER TOXICITY; LUNG TUBERCULOSIS; MALNUTRITION; MILIARY TUBERCULOSIS; NAUSEA; NEPHROTOXICITY; NEURITIS; NEUROTOXICITY; OPTIC NEURITIS; OTOTOXICITY; PARESTHESIA; PERIPHERAL NEUROPATHY; PHOTOSENSITIVITY; PRACTICE GUIDELINE; PYRIDOXINE DEFICIENCY; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; RETROBULBAR OPTIC NEUROPATHY; REVIEW; SIDE EFFECT; STEVENS JOHNSON SYNDROME; TOXIC HEPATITIS; TOXICITY; TREATMENT OUTCOME; TREATMENT PLANNING; TUBERCULOSIS; TUBERCULOUS MENINGITIS; URIC ACID BLOOD LEVEL;

ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; MALE; TUBERCULOSIS, PULMONARY; WORLD HEALTH ORGANIZATION;

EID: 70350009687     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2009.02375.x     Document Type: Review

References (70)

1. Al-Dossary FS, Ong LT, Correa AG Starke JR (2002) Treatment of childhood tuberculosis with a six month directly observed regimen of only two weeks of daily therapy. Pediatric Infectious Disease Journal 21, 91 97.
2. Beaudry PH, Brickman HF, Wise MB MacDougall D (1974) Liver enzyme disturbances during isoniazid chemoprophylaxis in children. American Review of Respiratory Disease 110, 581 584.
3. Biddulph J (1990) Short course chemotherapy for childhood tuberculosis. Pediatric Infectious Disease Journa 9, 794 801.
4. le Bourgeois M, de Blic J, Paupe J Scheinmann P (1989) Good tolerance of pyrazinamide in children with pulmonary tuberculosis. Archives of Disease in Childhood 64, 177 178.
5. Brasil MT, Opromolla DV, Marzliak ML Nogueira W (1996) Results of a surveillance system for adverse effects in leprosy's WHO/MDT. International Journal of Leprosy and Other Mycobacterial Diseases 64, 97 104.
6. Burman WJ Jones BE (2001) Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. American Journal of Respiratory and Critical Care Medicine 164, 7 12.
7. Centers for Disease Control and Prevention (2007). Managing drug interactions in the treatment of HIV-related tuberculosis [online]. Available at: http://www.cdc.gov/tb/publications/guidelines/TB-HIV-Drugs/default.htm (accessed on 28 August 2009)
8. Chintu C, Luo C, Bhat G et al. (1993) Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I. Archives of Disease in Childhood 68, 665 668.
9. Corrigan D Paton J (1999) Hepatic enzyme abnormalities in children on triple therapy for tuberculosis. Pediatric Pulmonology 27, 37 42.
10. Dash LA, Comstock GW Flynn JP (1980) Isoniazid preventive therapy: retrospect and prospect. American Review of Respiratory Diseases 121, 1039 1044.
11. Donald PR Schaaf HS (2007) Old and new drugs for the treatment of tuberculosis in children. Paediatric Respiratory Reviews 8, 134 141.
12. Donald PR, Schoeman JF O'Kennedy A (1987) Hepatic toxicity during chemotherapy for severe tuberculosis meningitis. American Journal of Disease in Children 141, 741 743.
13. Donald PR, Maher D, Maritz JS Qazi S (2006) Ethambutol dosage for the treatment of children: literature review and recommendations. International Journal of Tuberculosis and Lung Disease 10, 1318 1330.
14. Girling DJ (1984) The role of pyrazinamide in primary chemotherapy for pulmonary tuberculosis. Tubercle 65, 1 4.
15. Graham SM, Daley HM, Banerjee A, Salaniponi FM Harries AD (1998) Ethambutol in tuberculosis: time to reconsider? Archives of Disease in Childhood 79, 274 278.
16. Graham SM, Bell DJ, Nyirongo S et al. (2006) Low levels of pyrazinamide and ethambutol in children with tuberculosis and impact of age, nutritional status, and human immunodeficiency virus infection. Antimicrobial Agents and Chemotherapy 50, 407 413.
17. Harries AD, Parry C, Nyongonya Mbewe L et al. (1997) The pattern of tuberculosis in Queen Elizabeth Central Hospital, Blantyre, Malawi: 1986-1995. International Journal of Tuberculosis and Lung Disease 1, 346 351.
18. Harries AD, Hargreaves NJ, Graham SM et al. (2002) Childhood tuberculosis in Malawi: nationwide case-finding and treatment outcomes. International Journal of Tuberculosis and Lung Disease 6, 424 431.
19. Hill S, Regondi I, Grzemska M Matiru R (2008) Children and tuberculosis medicines: bridging the research gap. Bulletin of the World Health Organization 86, 658.
20. Hsu K (1984) Thirty years after isoniazid. Its impact on tuberculosis in children and adolescents. The Journal of the American Medical Association 251, 1283 1285.
21. Hussein A (1990) Short-term chemotherapy of tuberculosis in children. Pneumologie 44, 24 31.
22. Kabra SK, Lodha R Seth V (2004) Category based treatment of tuberculosis in children. Indian Pediatrics 41, 927 937.
23. Kopanoff DE, Snider DE Jr. Caras GJ (1978) Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study. American Review of Respiratory Diseases 117, 991 1001.
24. Kubota R, Ohno M, Hasunuma T, Iijima H Azuma J (2007) Dose-escalation study of isoniazid in healthy volunteers with the rapid acetylator genotype of arylamine N-acetyltransferase 2. European Journal of Clinical Pharmacology 63, 927 933.
25. Kumar L, Dhand R, Singhi PD, Rao KL Katariya S (1990) A randomized trial of fully intermittent vs. daily followed by intermittent short course chemotherapy for childhood tuberculosis. The Pediatric Infectious Disease Journal 9, 802 806.
26. Litt IF, Cohen MI McNamara H (1976) Isoniazid hepatitis in adolescents. Journal of Pediatrics 89, 133 135.
27. Lobato MN, Jereb JA Starke JR (2008) Unintended consequences: mandatory tuberculin skin testing and severe isoniazid hepatotoxicity. Pediatrics 121, e1732 1733.
28. Magdorf K, Arizzi-Rusche AF, Geiter LJ, O'Brien RJ Wahn U (1994) Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood-a pilot project. Pneumologie 48, 761 764.
29. Marais BJ, Graham SM, Cotton MF Beyers N (2007) Diagnostic and management challenges for childhood tuberculosis in the era of HIV. Journal of Infectious Disease 196 (Suppl. 1 S76 S85.
30. Mbala L, Matendo R Nkailu R (1998) Is vitamin B6 supplementation of isoniazid therapy useful in childhood tuberculosis. Tropical Doctor 28, 103 104.
31. McIlleron H, Willemse M, Werely CJ et al. (2009) Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines. Clinical Infectious Diseases 48, 1547 1553.
32. Morales SM Lincoln EM (1957) The effect of isoniazid therapy on pyridoxine metabolism in children. American Review of Tuberculosis 75, 594 600.
33. Nakajo MM, Rao M Steiner P (1989) Incidence of hepatotoxicity in children receiving isoniazid chemoprophylaxis. Pediatric Infectious Disease Journal 8, 649 650.
34. Nelson LJ Wells CD (2004) Global epidemiology of childhood tuberculosis. International Journal of Tuberculosis and Lung Disease 8, 636 647.
35. Nolan CM, Goldberg SV Buskin SE (1999) Hepatotoxicity associated with isoniazid preventive therapy. The Journal of the American Medical Association 281, 1014 1018.
36. Nunn P, Kibuga D, Gathua S et al. (1991) Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis. Lancet 337, 627 630.
37. O'Brien RJ, Long MW, Cross FS, Lyle MA Snider DE Jr. (1983) Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis. Pediatrics 72, 491 499.
38. Oeltmann JE, Chengeta B, Mboya JJ et al. (2008) Reported childhood tuberculosis treatment outcomes, Gaborone and Francistown, Botswana, 1998-2002. International Journal of Tuberculosis and Lung Disease 12, 186 192.
39. Ormerod LP (1987) Reduced incidence of tuberculosis by prophylactic chemotherapy in subjects showing strong reactions to tuberculin testing. Archives of Disease in Childhood 82, 1005 1008.
40. Ormerod LP (1998) Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis. Archives of Disease in Childhood 78, 169 171.
41. Ormerod LP Horsfield N (1996) Frequency and type of reactions to antituberculosis drugs: observations in routine treatment. Tubercle and Lung Disease 77, 37 42.
42. Padmini R, Srinivasan S, Nalini P Mahadevan S (1993) Short course chemotherapy for tuberculosis in children. Journal of Tropical Pediatrics 39, 361 364.
43. Palusci VJ, O'Hare D Lawrence RM (1995) Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children. The Pediatric Infectious Disease Journal 14, 144 148.
44. Parthasarathy R, Sarma GR, Janardhanam B et al. (1986) Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide. Tubercle 67, 99 108.
45. Pellock JM, Howell J, Kendig EL Jr. Baker H (1985) Pyridoxine deficiency in children treated with isoniazid. Chest 87, 658 661.
46. Possuelo LG, Castelan JA, de Brito TC et al. (2008) Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil. European Jouranl of Clinical Pharmacology 64, 673 681.
47. Ramachandran P (1980) Chemotherapy of tuberculous meningitis with isoniazid plus rifampicin: interim findings in a trial in children. Indian Journal of Tuberculosis 27, 54 57.
48. Rapp RS, Campbell RW, Howell JC Kendig EL Jr. (1978) Isoniazid hepatotoxicity in children. American Review of Respiratory Disease 118, 794 796.
49. Reed MD Blumer JL (1983) Clinical pharmacology of antitubercular drugs. Pediatric Clinics of North America 30, 177 193.
50. Robinson GC Cambon KG (1964) Hearing loss in infants of tuberculous mothers treated with streptomycin during pregnancy. New England Journal of Medicine 271, 949 951.
51. Robson JM Sullivan FM (1963) Antituberculosis drugs. Pharmacological Reviews 15, 169 223.
52. Sanchez-Albisua I, Vidal ML, Joya-Verde G et al. (1997) Tolerance of pyrazinamide in short course chemotherapy for pulmonary tuberculosis in children. The Pediatric Infectious Disease Journal 16, 760 763.
53. Schaaf HS, Parkin DP, Seifart HI et al. (2005) Isoniazid pharmacokinetics in children treated for respiratory tuberculosis. Archives of Disease in Childhood 90, 614 618.
54. Schaaf HS, Marais BJ, Whitelaw A et al. (2007) Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infectious Diseases 7, 140.
55. Spyridis P, Sinaniotis C, Papadea I, Oreopoulos L, Hadjiyiannis S Papadatos C (1979) Isoniazid liver injury during chemoprophylaxis in children. Archives of Disease in Childhood 54, 65 67.
56. Spyridis NP, Spyridis PG, Gelesme A et al. (2007) The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Clinical Infectious Disease 45, 715 722.
57. Swaminathan S, Raghavan A, Duraipandian M, Kripasankar AS Ramachandran P (2005) Short-course chemotherapy for paediatric respiratory tuberculosis: 5-year report. International Journal of Tuberculosis and Lung Disease 9, 693 696.
58. Te Water Naude JM, Donald PR, Hussey GD et al. (2000) Twice weekly vs. daily chemotherapy for childhood tuberculosis. The Pediatric Infectious Disease Journal 19, 405 410.
59. Tortajada C, Martinez-Lacasa J, Sánchez F et al. (2005) Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus? International Journal of Tuberculosis and Lung Disease 9, 276 281.
60. Tostmann A, Boeree MJ, Aarnoutse RE et al. (2008) Antituberculosis drug-induced hepatotoxicity: concise up-to-date review. Journal of Gastroenterology and Hepatology 23, 192 202.
61. Trebucq A (1997) Should ethambutol be recommended for routine treatment of tuberculosis in children? A review of the literature. International Journal of Tuberculosis and Lung Disease 1, 12 15.
62. Tsagaropoulou-Stinga H, Mataki-Emmanouilidou T, Karida-Kavalioti S Manios S (1985) Hepatotoxic reactions in children with severe tuberculosis treated with isoniazid-rifampin. Pediatric Infectious Disease Journal 4, 270 273.
63. Tsakalidis D, Pratsidou P, Hitoglou-Makedou A, Tzouvelekis G Sofroniadis I (1992) Intensive short course chemotherapy for treatment of Greek children with tuberculosis. The Pediatric Infectious Disease Journal 11, 1036 1042.
64. van Rie A, Beyers N, Gie RP et al. (1999) Childhood tuberculosis in an urban population in South Africa: burden and risk factor. Archives of Disease in Childhood 80, 433 437.
65. Villarino ME, Ridzon R, Weismuller PC et al. (1997) Rifampin preventive therapy for tuberculosis infection: experience with 157 adolescents. American Journal of Respiratory and Critical Care Medicine 155, 1735 1738. (Pubitemid 27216686)
66. World Health Organization (2006a) Guidance for national tuberculosis programmes on the management of tuberculosis in children. Document WHO-HTM-TB-2006.371. World Health Organization, Geneva, http://www.who.int/tb/ publications/2006/en/index.html.
67. World Health Organization (2006b) Revised TB recording and reporting forms and registers. Document WHO/HTM/TB/2006.373. World Health Organization, Geneva, http://www.who.int/tb/publications/2006/en/index.html.
68. World Health Organization (2006c) Ethambutol efficacy and toxicity: literature review and recommendations for daily and intermittent dosage in children. Document WHO-HTM-TB-2006.365. World Health Organization, Geneva, http://www.who.int/tb/publications/2006/en/index.html.
69. Wu SS, Chao CS, Vargas JH et al. (2007) Isoniazid-related hepatic failure in children: a survey of liver transplantation centers. Transplantation 84, 173 179.
70. Zhu M, Starke JR, Burman WJ et al. (2002) Population pharmacokinetic modeling of pyrazinamide in children and adults with tuberculosis. Pharmacotherapy 22, 686 695.